Disease Areas:
AsthmaDevice Types:
AsmaplanDOI:
10.3390/md23080328This randomized, double-blind, placebo-controlled trial investigated the effects of 20 weeks of treatment with daily salmon oil on respiratory outcomes in 66 adults with type 2 asthma. Respiratory outcomes included PEF, which was measured using a Vitalograph Asmaplan peak flow meter.